← FDA Drug Approvals (Drugs@FDA)

LABETALOL HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2019-02-04

Drug application

FDA Application #

ANDA207863

Application type

Abbreviated New Drug Application (Generic)

Brand name

LABETALOL HYDROCHLORIDE

Generic name

Labetalol Hydrochloride

Active ingredients

LABETALOL HYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

HIBROW HLTHCARE

First approval

2019-02-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown